Background: This retrospective study compared the efficacy, tolerability, and cost of two dihydropyridine calcium channel blockers.
Methods: Charts of patients who had been on continuous antihypertensive therapy with amlodipine or felodipine for at least 6 months were reviewed. Analyses include mean changes in blood pressure, percentage of patients achieving blood pressure (BP) < 140/90 mm Hg, average dose, and cost per day of the two calcium channel blockers, average cost of additional medication, total medication cost per day, and cost to achieve BP control.
Objective: To evaluate the effectiveness of ramipril in the prevention and treatment of cardiovascular disease and determine its need for inclusion on a formulary.
Data Sources: A MEDLINE and PubMed database search was conducted (1987-May 2002). Only journals written in the English language were selected for review.